Spontaneous Vaginal Delivery



FREE PREVIEW Log in or buy this issue to read the full article. AAFP members and paid subscribers get free access to all articles. Subscribe now.


FREE PREVIEW Subscribe or buy this issue. AAFP members and paid subscribers get free access to all articles.

Am Fam Physician. 2008 Aug 1;78(3):336-341.

The online version of this article includes supplemental content.

  Patient information: See related handout on labor and delivery, written by the authors of this article.

Vaginal delivery is a natural process that usually does not require significant medical intervention. Management guided by current knowledge of the relevant screening tests and normal labor process can greatly increase the probability of an uncomplicated delivery and postpartum course. All women should be screened for group B streptococcus; women who test positive should be treated with antibiotics during labor. Routine human immunodeficiency virus screening of all pregnant women, and treatment with antiretroviral medication for those who test positive, can reduce perinatal transmission of the infection. Once a woman is in labor, management should focus on the goal of delivering a healthy newborn while minimizing discomfort and complications for the mother. In a patient who tests negative for group B streptococcus, delaying admission to the labor ward until she is in active labor decreases the number of possible medical interventions during labor and delivery. Once a patient has been admitted to the hospital, providing her with continuous emotional support can improve delivery outcomes and the birthing experience. Epidural analgesia is effective for pain control and should not be discontinued late in labor to reduce the need for operative vaginal delivery. Epidurals prolong labor, but do not increase the risk of cesarean delivery. Research has shown that labor may not progress as rapidly as historically reported; this should be considered before intervening for dystocia. Routine episiotomy increases morbidity and should be abandoned. Once the infant has been delivered, active management of the third stage of labor decreases the risk of postpartum hemorrhage.

Spontaneous vaginal delivery at term has long been considered the preferred outcome for pregnancy. Because of the perceived health, economic, and societal benefits derived from vaginal deliveries, lowering the cesarean delivery rate has been a goal in the United States for more than 25 years.1 Although some experts now support elective primary cesarean delivery, and although the percentage of operative deliveries has increased from 21 percent in 1996 to 30 percent in 2005, most women still deliver vaginally.2  There are relatively few absolute contraindications to vaginal delivery (Table 1).35 In 2003, nearly 3 million vaginal deliveries occurred in the United States.2 Despite a decreasing trend in the number of family physicians providing maternity services, about 25 percent continue to perform vaginal deliveries, whereas less than 5 percent perform cesarean deliveries.6 Management guided by current knowledge of the relevant screening tests and normal labor process can greatly increase the probability of an uncomplicated delivery and postpartum course.

SORT: KEY RECOMMENDATIONS FOR PRACTICE

Clinical recommendation Evidence Rating References

All pregnant women should be screened for GBS at 35 to 37 weeks' gestation; women who test positive should be treated with appropriate antibiotics during labor.

C

8

All pregnant women should be screened for human immunodeficiency virus.

A

14

In GBS-negative women, admission to the labor ward at term should be delayed until the active phase of labor.

A

22

Epidural analgesia should not be discontinued late in labor to reduce the need for instrumental vaginal delivery.

A

26

Episiotomy should be restricted to use in situations in which it is clearly indicated, and should not be routinely used during normal vaginal delivery.

A

40, 41

The third stage of labor should be actively managed to reduce the risk of postpartum hemorrhage.

A

49


GBS = group B streptococcus.

A = consistent, good-quality patient-oriented evidence; B = inconsistent or limited-quality patient-oriented evidence; C = consensus, disease-oriented evidence, usual practice, expert opinion, or case series. For information about the SORT evidence rating system, see http://www.aafp.org/afpsort.xml.

SORT: KEY RECOMMENDATIONS FOR PRACTICE

View Table

SORT: KEY RECOMMENDATIONS FOR PRACTICE

Clinical recommendation Evidence Rating References

All pregnant women should be screened for GBS at 35 to 37 weeks' gestation; women who test positive should be treated with appropriate antibiotics during labor.

C

8

All pregnant women should be screened for human immunodeficiency virus.

A

14

In GBS-negative women, admission to the labor ward at term should be delayed until the active phase of labor.

A

22

Epidural analgesia should not be discontinued late in labor to reduce the need for instrumental vaginal delivery.

A

26

Episiotomy should be restricted to use in situations in which it is clearly indicated, and should not be routinely used during normal vaginal delivery.

A

40, 41

The third stage of labor should be actively managed to reduce the risk of postpartum hemorrhage.

A

49


GBS = group B streptococcus.

A = consistent, good-quality patient-oriented evidence; B = inconsistent or limited-quality patient-oriented evidence; C = consensus, disease-oriented evidence, usual practice, expert opinion, or case series. For information about the SORT evidence rating system, see http://www.aafp.org/afpsort.xml.

Table 1

Absolute Contraindications to Vaginal Delivery

Complete placenta previa

Herpes simplex virus with active genital lesions or prodromal symptoms

Previous classic uterine incision or extensive transfundal uterine surgery

Untreated human immunodeficiency virus infection


Information from references 3 through 5.

Table 1   Absolute Contraindications to Vaginal Delivery

View Table

Table 1

Absolute Contraindications to Vaginal Delivery

Complete placenta previa

Herpes simplex virus with active genital lesions or prodromal symptoms

Previous classic uterine incision or extensive transfundal uterine surgery

Untreated human immunodeficiency virus infection


Information from references 3 through 5.

Considerations Before Onset of Labor

GROUP B STREPTOCOCCUS

The vagina or rectum is colonized with group B streptococcus (GBS) in 10 to 40 percent of women.7,8 Early-onset GBS disease is the most common cause of serious infection during the newborn period; it occurs in one in 1,000 births.7 Universal screening consisting of a lower vaginal and rectal swab at 35 to 37 weeks' gestation and appropriate intra-partum chemoprophylaxis in GBS-positive women reduces the incidence of early-onset infections in neonates.8 Unless the bacteria are cultured from urine, there is no need for GBS treatment until the onset of labor. If GBS status is unknown at the start of labor, many physicians choose to treat prophylactically; however, this strategy is not recommended by the Centers for Disease Control and Prevention (CDC).8 Exceptions to these recommendations are noted in online Figure A, which is an algorithm for the prophylaxis of GBS during labor.8

In women who test positive for GBS or have other indications for prophylaxis, antibiotic therapy should be instituted at the onset of labor. Currently, preferred treatment consists of at least one dose of intravenous penicillin (5 million units) given a minimum of four hours before delivery. If labor continues beyond four hours, subsequent doses (2.5 million units) should be given every four hours until delivery. Although there is concern that GBS strains are becoming resistant to routinely administered antibiotics, no recent statistically significant increase in resistance has been noted.9 Ampicillin remains an alternative to penicillin; options for penicillin-allergic patients include cefazolin (Kefzol; brand not available in the United States), clindamycin (Cleocin), erythromycin, or vancomycin (Vancocin).8 The CDC recommends treatment based on GBS sensitivity patterns in women who are at high risk of anaphylaxis with penicillin.8

HERPES SIMPLEX VIRUS

Twenty-two percent of pregnant women in the United States have been exposed to herpes simplex virus (HSV) type 2.10 Congenital and neonatal HSV infections can be catastrophic to the newborn, and maternal HSV infection often raises concerns during pregnancy and labor. HSV infection in pregnancy should be treated with standard doses of antiviral medications. Acyclovir (Zovirax), ganciclovir (Cytovene), and valacyclovir (Valtrex) are all classified as U.S. Food and Drug Administration pregnancy category B and are routinely used during pregnancy. A primary outbreak of HSV confers a higher risk of neonatal infection than does a recurrent episode.11 Cesarean delivery is recommended for all women with active genital lesions or symptoms consistent with the prodrome of HSV at the time of labor.12 Although acyclovir does not eliminate viral shedding, prophylactic treatment from 36 weeks' gestation until delivery is recommended to prevent recurrence at term and to reduce the need for cesarean delivery.12

HUMAN IMMUNODEFICIENCY VIRUS

From 2001 to 2005, the rate of perinatal transmission of human immunodeficiency virus (HIV) in the United States has been reduced by more than 50 percent.13 Routine HIV screening of all pregnant women is strongly recommended.14 Antiretroviral therapy throughout pregnancy and cesarean delivery after 38 weeks' gestation have been shown to reduce the risk of vertical transmission of HIV.5,15,16 Vaginal delivery can be considered for patients who are receiving antiretroviral therapy and have low viral loads (less than 1,000 copies per mL).3,5

LENGTH OF GESTATION

A normal gestation lasts 40 weeks after the first day of the most recent menstrual period, and term gestation is defined at 37 to 42 weeks. In the United States, only 7 percent of pregnancies will extend beyond 42 weeks.17 In an uncomplicated pregnancy, there is no fetal or maternal benefit to induction before 41 weeks' gestation.17

Labor

Labor is defined as the onset of regular contractions and cervical change. It is traditionally divided into three stages. The first stage encompasses the onset of labor to the complete dilatation of the cervix, and is subdivided into latent and active phases. The active phase begins when the rate of cervical dilatation accelerates, which occurs at 4 cm on average. The second stage consists of the time from complete dilatation of the cervix to delivery of the infant. The third stage is complete at the delivery of the placenta. The original labor curves were plotted by Friedman in the 1950s and are the traditional basis for defining prolonged labor patterns.18 Subsequent studies included more patients receiving epidural analgesia and demonstrated a slower average progression of labor than seen in the Friedman curve.19-21  This suggests that more time should be allowed than previously recommended before intervening to hasten labor. Table 2 lists the range of average lengths and upper limits of normal for each stage of labor.1821

Table 2

Average Lengths and Upper Limits of Normal for Stages of Labor in Primiparous and Multiparous Women

Stage of labor Lengths
Primiparous women Multiparous women

First (latent phase)

5.9 to 6.4 (25.1*) hours

4.8 (13.6*) hours

First (active phase)

3.3 to 7.7 (17.5*) hours

3 to 7 (13.8*) hours

Second

33 to 54 (146*) minutes

8.5 to 18 (64*) minutes

Third

5 (30*) minutes

5 (30*) minutes


*— Upper limit of normal.

Information from references 18 through 21.

Table 2   Average Lengths and Upper Limits of Normal for Stages of Labor in Primiparous and Multiparous Women

View Table

Table 2

Average Lengths and Upper Limits of Normal for Stages of Labor in Primiparous and Multiparous Women

Stage of labor Lengths
Primiparous women Multiparous women

First (latent phase)

5.9 to 6.4 (25.1*) hours

4.8 (13.6*) hours

First (active phase)

3.3 to 7.7 (17.5*) hours

3 to 7 (13.8*) hours

Second

33 to 54 (146*) minutes

8.5 to 18 (64*) minutes

Third

5 (30*) minutes

5 (30*) minutes


*— Upper limit of normal.

Information from references 18 through 21.

FIRST STAGE OF LABOR

Patients in labor are usually admitted to the hospital during the first stage of labor. It is important to differentiate between the active and latent phases because women admitted in latent labor tend to spend more time in the labor ward and have more interventions than those whose admission is delayed until the active phase.22 When a patient is admitted during the latent phase, physicians should set reasonable expectations for labor progress to avoid unnecessary interventions and anxiety. In GBS-negative women who are at term, admission to the labor ward should be delayed until the active phase of labor begins.22

The most common intervention in the first stage of labor is pain control. There are numerous nonpharmacologic methods available to ease the discomfort of labor and improve the experience, including positioning, ambulation, massage, aromatherapy, and acupressure. However, there are limited published data available on these methods. One Cochrane review showed that acupuncture and hypnosis may be beneficial for pain control.23 Another Cochrane review found that women should have continuous support throughout labor and delivery to decrease the need for epidural analgesia and operative delivery and to improve the childbirth experience.24

Pharmacologic pain control is often used during labor; the most common interventions are intravenous narcotics and epidural analgesia. Epidurals have been shown to effectively decrease pain during labor, but may lead to an increase in instrumental vaginal delivery.25 Instruments may be employed more often because epidural analgesia lengthens the second stage of labor, prompting intervention for a perceived dystocia.25 Discontinuing epidurals late in labor decreases pain control and does not decrease the need for instrumental delivery.26 Patients who choose epidurals do not increase their risk of having a cesarean delivery.25 Physicians should expect patients who receive an epidural to have adequate pain control and to progress less rapidly than predicted by the Friedman curve. Understanding this delay can prevent unnecessary interventions.

Fetal heart rate monitoring during labor has become common in the United States; it was used in 85 percent of deliveries in 2002.27 Monitoring is used to determine the well-being of the fetus. The high false-positive rate of fetal heart rate monitoring is well recognized, and its continuous use increases cesarean and operative vaginal deliveries without decreasing overall perinatal mortality or the incidence of cerebral palsy.27 The addition of fetal pulse oximetry does not decrease the need for cesarean delivery, and there is no evidence to support its use at this time.28,29 Fetal electrocardiogram (ECG) monitoring is a newer technology that has shown potential because it reduces acidosis and the need for operative vaginal delivery when used as an adjunct to continuous fetal heart rate monitoring. Fetal ECG monitoring requires internal electrodes and ruptured membranes to record waveforms.30 Further study needs to be done before the use of fetal ECG can be recommended.

SECOND STAGE OF LABOR

During the second stage of labor, the fetus descends through the maternal pelvis and is ultimately expelled. Tremendous stress is placed on the passageway, often resulting in trauma to the genitourinary tract, most commonly the perineum. Spontaneous tears that require suturing occur in approximately one third of women in the United States, and anal sphincter tears occur in less than 1 percent.31

Reduction in perineal trauma is desirable because affected women have an increased risk of long-term perineal pain, long-term dyspareunia, urinary problems, and fecal incontinence.31 Antenatal perineal massage can reduce the need for laceration repair or episiotomy, and can reduce prolonged pain in women without prior vaginal delivery.32 Although these benefits were modest, the technique has no known deleterious effects and may be beneficial in some primigravidas.

Maternal pushing methods can impact second-stage outcomes. Coached pushing with sustained breath holding (closed glottis pushing) results in a slightly shorter second stage (by 13 minutes) compared with spontaneous exhalatory pushing (open glottis pushing).33 Delayed pushing (i.e., waiting until the maternal urge to push is strong instead of encouraging pushing immediately at complete cervical dilatation) prolongs the second stage of labor, but shortens the duration of pushing34 and results in an increased number of spontaneous deliveries.35 Varying techniques of pushing have not been shown to impact perinatal mortality or perineal trauma.33,35

There is conflicting evidence about maternal position in the second stage of labor. Upright or lateral position may allow more effective pushing and may be preferred by some patients to the supine position with stirrups. Because good evidence is lacking to support one particular birthing position, the patient should be allowed to deliver in the position most comfortable for her.36

Delivery techniques vary by region and physician. Attempts have been made to determine the best ways to guide the process of labor. Studies comparing the “hands poised” technique (i.e., not touching the baby's head or supporting the mother's perineum until delivery of the head) with the “hands on” technique (i.e., applying pressure to the baby's head during delivery and supporting the mother's perineum) have shown no major differences in outcomes, including rates of perineal trauma and tears.37,38 Patients delivering via the “hands poised” technique were less likely to have episiotomies, but had a slightly higher risk of perineal pain after delivery.37 Given the subtle differences in outcomes, either approach to delivery is appropriate.

Episiotomy, an intentional incision in the perineum, was first introduced in the United States in 1850, but it did not become common until the 1920s.31 More than 2 million episiotomies were performed in 1981; this decreased to about 1 million in 1997.39 These numbers appear to be heavily driven by local norms, physician experience in training, and physician preference.40

Recently, the idea of restrictive episiotomy has gained acceptance. Compared with routine use, limiting episiotomy to use when indicated increases the likelihood of maintaining an intact perineum and decreases healing complications. Although restrictive episiotomy increases the risk of anterior perineal trauma, there is no significant difference in risk of third-degree tears, dyspareunia, or urinary incontinence compared with routine episiotomy.41 Benefits of restrictive episiotomy are seen with median and mediolateral episiotomy.42 The practice of routine episiotomy should be abandoned.

Nonsuturing of the perineal skin in first- and second-degree tears and episiotomies results in less pain for up to three months after delivery43 and less dyspareunia at three months after delivery.44 Nonsuturing of the muscle layers is not recommended because of poorer wound healing at six weeks postpartum.45 When repair of the perineum is required, use of a continuous, knotless technique is preferred over interrupted suturing. The knotless technique reduces short-term pain and the need for postpartum suture removal without compromising wound healing or long-term outcomes.46 Repair with absorbable synthetic suture is preferred to catgut. Synthetic suture decreases analgesic use47 and decreases dyspareunia at 12 months.48

THIRD STAGE OF LABOR

During the third stage of labor, the uterine muscle must contract adequately to slow maternal blood loss once the placenta separates from the uterine wall.49 A prolonged third stage of labor, which is diagnosed after 30 minutes if spontaneous placental delivery does not occur, may require further intervention.

Postpartum hemorrhage is defined as excess blood loss from the uterus (more than 500 mL) during and after delivery. Causes of postpartum hemorrhage include uterine atony, retained tissue, trauma to the genital tract, and coagulopathies.50

Active management of the third stage of labor includes administration of an oxytocic agent after delivery of the anterior shoulder, early cord clamping, and controlled cord traction. This management decreases maternal blood loss, risk of postpartum hemorrhage, length of the third stage, and the need for blood transfusion.49 Despite an increase in maternal nausea and vomiting, active management of the third stage is strongly encouraged.49 Placental cord drainage, which involves clamping and cutting the cord after delivery and then immediately unclamping the maternal side (allowing blood to drain freely), decreases the length of the third stage of labor.50,51

Table 3 provides a summary of beneficial and non-beneficial interventions in spontaneous vaginal delivery.5,8,12,1417,2224,2628,3238,41,43,44,4651

Table 3

Summary of Beneficial and Nonbeneficial Interventions in Spontaneous Vaginal Delivery

Interventions that improve outcomes

Universal screening for GBS at 35 to 37 weeks' gestation8

Administration of antibiotics at the onset of labor in GBS-positive women8

Use of penicillin as a first-line antibiotic for treatment of GBS in labor 8

Treatment of HSV with standard antiviral therapy during pregnancy12

Cesarean delivery for women with active genital lesions or symptoms consistent with the prodrome of HSV at the onset of labor12

Prophylaxis with antivirals from 36 weeks' gestation until delivery in women with a history of HSV infection12

Universal HIV screening in all pregnant women14

Cesarean delivery for women with untreated HIV infection at onset of labor 5,15,16

Delayed admission to the labor ward until the active phase of labor in GBS-negative women22

Continuous support during labor and delivery 24

Antenatal perineal massage to prevent perineal trauma in primigravidas32

Coached pushing and delayed pushing techniques in the second stage of labor3335

Nonsuturing of the perineal skin in first- and second-degree tears43,44

Continuous, knotless repair of episiotomy or perineal tear 46

Use of absorbable synthetic suture instead of catgut to repair perineal tears and episiotomies47,48

Active management of the third stage of labor 49

Placental cord drainage in the third stage of labor 50,51

Interventions that are neutral or that worsen outcomes

Administration of antibiotics before the onset of labor in GBS-positive women8

Induction before 41 weeks' gestation in an uncomplicated pregnancy17

Use of positioning, ambulation, massage, aromatherapy, or acupressure for pain control in labor23

Discontinuation of epidural analgesia late in labor to avoid the need for instrumental delivery 26

Universal continuous fetal heart rate monitoring27

Fetal pulse oximetry 28

Upright, lateral, or supine positioning to improve outcomes in the second stage of labor 36

“Hands poised” or “hands on” technique to prevent perineal trauma or tears37,38

Routine episiotomy 41


GBS = group B streptococcus; HIV = human immunodeficiency virus; HSV = herpes simplex virus.

Information from references 5, 8, 12, 14 through 17, 22 through 24, 26 through 28, 32 through 38, 41, 43, 44, and 46 through 51.

Table 3   Summary of Beneficial and Nonbeneficial Interventions in Spontaneous Vaginal Delivery

View Table

Table 3

Summary of Beneficial and Nonbeneficial Interventions in Spontaneous Vaginal Delivery

Interventions that improve outcomes

Universal screening for GBS at 35 to 37 weeks' gestation8

Administration of antibiotics at the onset of labor in GBS-positive women8

Use of penicillin as a first-line antibiotic for treatment of GBS in labor 8

Treatment of HSV with standard antiviral therapy during pregnancy12

Cesarean delivery for women with active genital lesions or symptoms consistent with the prodrome of HSV at the onset of labor12

Prophylaxis with antivirals from 36 weeks' gestation until delivery in women with a history of HSV infection12

Universal HIV screening in all pregnant women14

Cesarean delivery for women with untreated HIV infection at onset of labor 5,15,16

Delayed admission to the labor ward until the active phase of labor in GBS-negative women22

Continuous support during labor and delivery 24

Antenatal perineal massage to prevent perineal trauma in primigravidas32

Coached pushing and delayed pushing techniques in the second stage of labor3335

Nonsuturing of the perineal skin in first- and second-degree tears43,44

Continuous, knotless repair of episiotomy or perineal tear 46

Use of absorbable synthetic suture instead of catgut to repair perineal tears and episiotomies47,48

Active management of the third stage of labor 49

Placental cord drainage in the third stage of labor 50,51

Interventions that are neutral or that worsen outcomes

Administration of antibiotics before the onset of labor in GBS-positive women8

Induction before 41 weeks' gestation in an uncomplicated pregnancy17

Use of positioning, ambulation, massage, aromatherapy, or acupressure for pain control in labor23

Discontinuation of epidural analgesia late in labor to avoid the need for instrumental delivery 26

Universal continuous fetal heart rate monitoring27

Fetal pulse oximetry 28

Upright, lateral, or supine positioning to improve outcomes in the second stage of labor 36

“Hands poised” or “hands on” technique to prevent perineal trauma or tears37,38

Routine episiotomy 41


GBS = group B streptococcus; HIV = human immunodeficiency virus; HSV = herpes simplex virus.

Information from references 5, 8, 12, 14 through 17, 22 through 24, 26 through 28, 32 through 38, 41, 43, 44, and 46 through 51.

The Authors

DALE A. PATTERSON, MD, FAAFP, is associate director of the Family Medicine Residency Program at Memorial Hospital of South Bend (Ind.). He received his medical degree from Michigan State University College of Human Medicine in East Lansing, and completed a family medicine residency at Memorial Hospital of South Bend.

MARGUERITE WINSLOW, MD, is chief resident of The Toledo (Ohio) Hospital Family Medicine Residency Program. She received her medical degree from the Medical College of Ohio at Toledo (now called the University of Toledo).

CORAL D. MATUS, MD, is associate director of The Toledo Hospital Family Medicine Residency Program. She received her medical degree from The Ohio State University in Columbus, and completed a family medicine residency at The Toledo Hospital and a faculty development fellowship at the University of Michigan in Ann Arbor.

Address correspondence to Dale A. Patterson, MD, FAAFP, 714 N. Michigan, South Bend, IN 46601 (e-mail: dalepatterson@pol.net). Reprints are not available from the authors.

Author disclosure: Nothing to disclose.

REFERENCES

1. National Institutes of Health. Cesarean childbirth. Consensus development conference statement. September 22–24, 1980. http://consensus.nih.gov/1980/1980Cesarean027html.htm. Accessed February 13, 2008.

2. Hamilton BE, Martin JA, Ventura SJ, for the Division of Vital Statistics. Births: preliminary data for 2005. Hyattsville, Md.: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics. http://www.cdc.gov/nchs/products/pubs/pubd/hestats/prelimbirths05/prelimbirths05.htm. Accessed February 13, 2008.

3. Public Health Service Task Force, Perinatal HIV-1 Guidelines Working Group. Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. October 12, 2006. http://www.ucsf.edu/hivcntr/Perinatal/PerinatalGL.pdf. Accessed February 13, 2008.

4. ACOG practice bulletin #54: vaginal birth after previous cesarean. Obstet Gynecol. 2004;104(1):203–212.

5. Committee on Obstetric Practice. ACOG committee opinion scheduled cesarean delivery and the prevention of vertical transmission of HIV infection. No. 234, May 2000. Int J Gynaecol Obstet. 2001;73(3):279–281.

6. American Academy of Family Physicians. Practice Profile Survey II. May 2005. Leawood, Kan.: American Academy of Family Physicians, 2005.

7. Woodgate P, Flenady V, Steer P. Intramuscular penicillin for the prevention of early onset group B streptococcal infection in newborn infants. Cchrane Database Syst Rev. 2004;(3):CD003667.

8. Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep. 2002;51(RR-11):1–22.

9. Chohan L, Hollier LM, Bishop K, Kilpatrick CC. Patterns of antibiotic resistance among group B streptococcus isolates: 2001–2004. Infect Dis Obstet Gynecol. 2006;2006:57492.

10. Xu F, Markowitz LE, Gottlieb SL, Berman SM. Seroprevalence of herpes simplex virus types 1 and 2 in pregnant women in the United States. Am J Obstet Gynecol. 2007;196(1):43.e1–6.

11. Brown ZA, Wald A, Morrow RA, Selke S, Zeh J, Corey L. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA. 2003;289(2):203–209.

12. ACOG Committee on Practice Bulletins. ACOG practice bulletin. Clinical management guidelines for obstetrician-gynecologists. No. 82, June 2007. Management of herpes in pregnancy. Obstet Gynecol. 2007;109(6):1489–1498.

13. Centers for Disease Control and Prevention. Cases of HIV infection and AIDS in the United States and dependent areas, 2005. HIV/AIDS Surveillance Report. 2005;17. Atlanta, Ga.: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2007. http://www.cdc.gov/hiv/topics/surveillance/resources/reports/2005report/pdf/2005SurveillanceReport.pdf. Accessed February 13, 2008.

14. U.S. Preventive Services Task Force. Screening for HIV: recommendation statement. AHRQ Publication No. 07–0597-EF-2. Rockville, Md.: Agency for Healthcare Research and Quality; 2007. http://www.ahrq.gov/clinic/uspstf05/hiv/hivrs.htm. Accessed February 13, 2008.

15. Volmink J, Siegfried NL, van der Merwe L, Brocklehurst P. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database Syst Rev. 2007;(1):CD003510.

16. Brocklehurst P. Interventions for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database Syst Rev. 2002;(1):CD000102.

17. U.S. Department of Health and Human Services, Agency for Healthcare Research and Quality. Management of prolonged pregnancy. Rockville, Md.: Agency for Healthcare Research and Quality; 2002. AHRQ Publication No. 02-E012. http://www.ahrq.gov/clinic/epcsums/prolongsum.htm. Accessed February 13, 2008.

18. Friedman EA. Labor: Clinical Evaluation and Management. 2nd ed. New York, NY: Appleton-Century-Crofts; 1978:49.

19. Duignan NM, Studd JW, Hughes AO. Characteristics of normal labour in different racial groups. Br J Obstet Gynaecol. 1975;82(8):593–601.

20. Albers LL. The duration of labor in healthy women. J Perinatol. 1999;19(2):114–119.

21. Zhang J, Troendle JF, Yancey MK. Reassessing the labor curve in nulliparous women. Am J Obstet Gynecol. 2002;187(4):824–828.

22. Lauzon L, Hodnett E. Labour assessment programs to delay admission to labour wards. Cochrane Database Syst Rev. 2001;(3):CD000936.

23. Smith CA, Collins CT, Cyna AM, Crowther CA. Complementary and alternative therapies for pain management in labour. Cochrane Database Syst Rev. 2006;(4):CD003521.

24. Hodnett ED, Gates S, Hofmeyr GJ, Sakala C. Continuous support for women during childbirth. Cochrane Database Syst Rev. 2007;(3):CD003766.

25. Anim-Somuah M, Smyth R, Howell C. Epidural versus non-epidural or no analgesia in labour. Cochrane Database Syst Rev. 2005;(4):CD000331.

26. Torvaldsen S, Roberts CL, Bell JC, Raynes-Greenow CH. Discontinuation of epidural analgesia late in labour for reducing the adverse delivery outcomes associated with epidural analgesia. Cochrane Database Syst Rev. 2004;(4):CD004457.

27. ACOG Committee on Practice Bulletins. ACOG practice bulletin. Clinical management guidelines for obstetrician-gynecologists. No. 62, May 2005. Intrapartum fetal heart rate monitoring. Obstet Gynecol. 2005;105(5 pt 1):1161–1169.

28. East CE, Chan FY, Colditz PB, Begg LM. Fetal pulse oximetry for fetal assessment in labour. Cochrane Database Syst Rev. 2007;(2):CD004075.

29. Klauser CK, Christensen EE, Chauhan SP, et al. Use of fetal pulse oximetry among high-risk women in labor: a randomized clinical trial. Am J Obstet Gynecol. 2005;192(6):1810–1817.

30. Neilson JP. Fetal electrocardiogram (ECG) for fetal monitoring during labour. Cochrane Database Syst Rev. 2006;(3):CD000116.

31. Kettle C. Perineal care. Clin Evid. 2006;(15):1904–1918.

32. Beckmann MM, Garrett AJ. Antenatal perineal massage for reducing perineal trauma. Cochrane Database Syst Rev. 2006;(1):CD005123.

33. Bloom SL, Casey BM, Schaffer JI, McIntire DD, Leveno KJ. A randomized trial of coached versus uncoached maternal pushing during the second stage of labor. Am J Obstet Gynecol. 2006;194(1):10–13.

34. Roberts CL, Torvaldsen S, Cameron CA, Olive E. Delayed versus early pushing in women with epidural analgesia: a systematic review and meta-analysis. BJOG. 2004;111(12):1333–1340.

35. Menez-Orieux C, Linet T, Philippe HJ, Boog G. Delayed versus immediate pushing in the second stage of labor for nulliparous parturients with epidural analgesia: a meta-analysis of randomized trials [in French]. J Gynecol Obstet Biol Reprod (Paris). 2005;34(5):440–447.

36. Gupta JK, Hofmeyr GJ. Position for women during second stage of labour. Cochrane Database Syst Rev. 2004;(1):CD002006.

37. McCandlish R, Bowler U, van Asten H, et al. A randomised controlled trial of care of the perineum during second stage of normal labour. Br J Obstet Gynaecol. 1998;105(12):1262–1272.

38. Mayerhofer K, Bodner-Adler B, Bodner K, et al. Traditional care of the perineum during birth. A prospective, randomized, multicenter study of 1,076 women. J Reprod Med. 2002;47(6):477–482.

39. Weber AM, Meyn L. Episiotomy use in the United States 1979–1997. Obstet Gynecol. 2002;100(6):1177–1182.

40. Agency for Healthcare Research and Quality. The use of episiotomy in obstetrical care: a systematic review. AHRQ Publication No. 05–E009–1. Rockville, Md.: Agency for Healthcare Research and Quality; 2005. http://www.ahrq.gov/clinic/tp/epistp.htm. Accessed November 20, 2007.

41. Carroli G, Belizan J. Episiotomy for vaginal birth. Cochrane Database Syst Rev. 2000;(2):CD000081.

42. Coats PM, Chan KK, Wilkins M, Beard RJ. A comparison between midline and mediolateral episiotomies. Br J Obstet Gynaecol. 1980;87(5):408–412.

43. Gordon B, Mackrodt C, Fern E, Truesdale A, Ayers S, Grant A. The Ipswich Childbirth Study: 1. A randomised evaluation of two stage post-partum perineal repair leaving the skin unsutured. Br J Obstet Gynaecol. 1998;105(4):435–440.

44. Oboro VO, Tabowei TO, Loto OM, Bosah JO. A multicentre evaluation of the two-layered repair of postpartum perineal trauma. J Obstet Gynaecol. 2003;23(1):5–8.

45. Lundquist M, Olsson A, Nissen E, Norman M. Is it necessary to suture all lacerations after a vaginal delivery? Birth. 2000;27(2):79–85.

46. Kettle C, Johanson RB. Continuous versus interrupted sutures for repair of episiotomy or second degree tears. Cochrane Database Syst Rev. 2007;(4):CD000947.

47. Kettle C, Johanson RB. Absorbable synthetic versus catgut suture material for perineal repair. Cochrane Database Syst Rev. 2000;(2):CD000006.

48. Grant A, Gordon B, Mackrodat C, Fern E, Truesdale A, Ayers S. The Ipswich childbirth study: one year follow up of alternative methods used in perineal repair. BJOG. 2001;108(1):34–40.

49. Prendiville WJ, Elbourne D, McDonald S. Active versus expectant management in the third stage of labour. Cochrane Database Syst Rev. 2000;(3):CD000007.

50. Anderson J, Etches D, Smith D. Postpartum hemorrhage: third stage emergency. In: Advanced Life Support in Obstetrics Syllabus. Leawood, Kan.: American Academy of Family Physicians; 2005:Section J, 2–3.

51. Soltani H, Dickinson F, Symonds I. Placental cord drainage after spontaneous vaginal delivery as part of the management of the third stage of labour. Cochrane Database Syst Rev. 2005;(4):CD004665.


Copyright © 2008 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact afpserv@aafp.org for copyright questions and/or permission requests.

Want to use this article elsewhere? Get Permissions


Article Tools

  • Download PDF
  • Print page
  • Share this page
  • AFP CME Quiz

Information From Industry

More in Pubmed

Navigate this Article